Edoxaban versus Warfarin in Patients with Atrial Fibrillation
ENGAGE-TIMI 48 trial BACKGROUNDEdoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with… Weiterlesen »Edoxaban versus Warfarin in Patients with Atrial Fibrillation